Abstract Buphenine (nylidrin), a β-adrenergic agonist, is used therapeutically for its vasodilating effect on the peripheral circulation and possibly on the cerebral circulation as well. In spite of its ophthalmic usage in degenerative retinal disease and glaucoma, buphenine's ocular effects and their mechanisms are not sufficiently established. Consquently, we studied the action of 4.5–120 μM buphenine in isolated, arterially perfused cat eyes, and then used light-evoked electrical signals, perfusion flow rates and the diameters of the retinal vessels as parameters for the drug's effect. Our findings showed that buphenine induced a marked, dose-related, reversible increase in the amplitude of the electroretinogram (ERG) b-wave, a decrease in the c-wave, but no significant changes in the standing potential and light peak of the DC-ERG. The compound action potential of the optic nerve revealed dose-dependent and reversible changes in configuration. However, the flow of perfusate was not affected by the drug, and the diameter of retinal vessels did not change significantly. Our studies suggest that the interaction of buphenine with retinal adrenergic receptors is not related to the vasculature present but to elements involved in information processing. It is likely that these receptors are linked to neurons, since the β-agonist affected the ERG b-waves as well as the compound action potential of the optic nerve.
ophthalmic          0.9999996153287214^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Human_eye             

receptors                     0.9999999756932997^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Receptor_(biochemistry)

ERG                           0.8998269167233663^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Ergative_case         

neurons                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Neuron                

retinal                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Retina                

disease                       0.9886351149598193^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Disease               

action potential              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Action_potential      

amplitude                     0.999999999282636^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Amplitude             

compound                      0.9999952731925833^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Eye                   

adrenergic                    0.9999999871076853^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Adrenergic_receptor   

cerebral circulation          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cerebral_circulation  

reversible                    0.9981037556404732^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Enzyme_inhibitor      

glaucoma                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Glaucoma              

perfused                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Perfusion             

vasodilating                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Vasodilation          

drug                          0.9993136039656948^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Drug                  

β-adrenergic                  0.9999999999998863^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Adrenergic_receptor   

μM                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Molar_concentration   

vasculature                   0.999585078370048^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Blood_vessel          

peripheral circulation        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Systemic_circulation  

compound                      0.9999952731925833^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Eye                   

retinal                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Retina                

cat                           0.9999991872100401^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cat                   

optic nerve                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Optic_nerve           

ocular                        0.9999999954466148^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Human_eye             

retinal                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Retina                

optic nerve                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Optic_nerve           

drug                          0.9993136039656948^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Drug                  

reversible                    0.9981037556404732^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Enzyme_inhibitor      

retinal                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Retina                

dose-dependent                0.8915938114609093^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Dose_(biochemistry)   

agonist                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Agonist               

light peak                    0.9999999999998863^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Thunderbolt_(interface)

ERG                           0.8998269167233663^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Ergative_case         

perfusion                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Perfusion             

receptors                     0.9999999756932997^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Receptor_(biochemistry)

action potential              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Action_potential      

electroretinogram             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Electroretinography   

